This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Online talk: ask the experts about COVID-19 vaccine research

Online talk: ask the experts about COVID-19 vaccine research

Join healthcare specialists working in COVID-19 vaccine research in the South of England to learn what we know about COVID-19 vaccines so far and the role research can continue to play.

With three COVID-19 vaccines approved and more trials still recruiting, our expert panel will be available to answer questions, including:

  • How was the vaccine developed and approved so quickly?
  • Why do we need more vaccine research?
  • What research is being conducted into groups which cannot have the licensed vaccines, pregnant women and children?

This Zoom event will be held on Wednesday 17 March from 7pm to 8pm and hosted by the National Institute for Health Research. It will be chaired by the Lord-Lieutenant of the City and County of Bristol, Peaches Golding OBE. Sign up on Eventbrite.

Panel members:

Professor Saul Faust 

Saul Faust FRCPCH PhD, is Professor of Paediatric Immunology & Infectious Diseases at the University of Southampton, Director of the National Institute for Health Research (NIHR) Southampton Clinical Research Facility, Clinical Director of the Clinical Research Network (CRN) Wessex and a NIHR Senior Investigator. 

Professor Adam Finn

Professor Adam Finn has been instrumental to COVID-19 vaccine research in Bristol, as part of the University's COVID-19 Emergency Research Group (UNCOVER). He has worked on delivering a number of vaccine trials including Oxford/AstraZeneca, Janssen and Valneva. Professor Finn sits on the Joint Committee on Vaccination and Immunisation (JCVI) and is the Clinical Divisional Lead for Division 3 at the Clinical Research Network West of England.

Dr Lawrence Barnes

Rame Group Practice, Cornwall

Dr Barnes is the local PI for the PROVENT study (AstraZeneca’s COVID-19 long-acting antibody combination) which is looking at whether giving antibodies to people can provide protection for those who would not be eligible for the vaccine. Dr Barnes, who qualified as a GP in 1996, began research in 2003 and has worked on a broad range of research areas from cardiovascular risk factors, mental health, dementia and immunisation.

Sarah Wytrykowski 

Lead Research Nurse Vaccine Trials, NIHR Clinical Research Network: Thames Valley and South Midlands. She said: “My role includes supporting clinical trial and study delivery to ensure that quality, rigour and appropriate governance is maintained. I am responsible for prioritisation and allocation of resources to ensure that studies are set up efficiently within tightly defined timescales.”